Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients.

Rita IndirliAlessandra BanderaLuca Vittorio ValentiFerruccio CeriottiAdriana Di ModugnoMauro TettamantiRoberta GualtierottiFlora PeyvandiNicola MontanoFrancesco BlasiGiorgio CostantinoVeronica ResiEmanuela OrsiArosio Maura Mantovani Giovanna Emanuele Ferrantenull null

Published in: European journal of clinical investigation (2022)

Admission MR-proADM and copeptin may be implemented for early risk stratification in COVID-19-hospitalized patients to help identify those eligible for closer monitoring and care intensification.

Keyphrases

coronavirus disease
sars cov
healthcare
emergency department
palliative care
respiratory syndrome coronavirus
quality improvement
contrast enhanced
pain management